Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study

No abstract is available for this paper.

• Publication year

  2013

• Venue

  World Journal of Surgery

• Publication date

  2013-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00268-013-2074-xPMID 23649529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Failure patterns in patients with esophageal cancer treated with definitive chemoradiation

  2012cited by this paper
• Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs

  2012cited by this paper
• A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

  2011cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.

  2009cited by this paper
• Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

  2007cited by this paper
• Treatment of thoracic esophageal carcinoma invading adjacent structures

  2007cited by this paper
• Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluorouracil and cis-diammine-dichloro-platinum (CDDP)

  2007cited by this paper
• Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

  2005cited by this paper
• Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).

  2004cited by this paper
• Esophagectomy: Is It Necessary after Chemoradiotherapy for a Locally Advanced T4 Esophageal Cancer? Prospective Nonrandomized Trial Comparing Chemoradiotherapy with Surgery versus without Surgery

  2004cited by this paper
• Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus

  2003cited by this paper
• Role of Esophagectomy in Treatment of Esophageal Carcinoma with Clinical Evidence of Adjacent Organ Invasion

  2001cited by this paper
• Concurrent chemotherapy (5‐fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus

  1999cited by this paper
• Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.

  1999cited by this paper
• Outcomes of extended radical esophagectomy for thoracic esophageal cancer.

  1998cited by this paper
• First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.

  1997cited by this paper
• Intramural Metastases from Thoracic Esophageal Cancer: Local Indicators of Advanced Disease

  1996cited by this paper

• German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0

  2025cites this paper
• Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review

  2025influential citation
• S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus

  2024cites this paper
• Locally Advanced Adenocarcinoma of the Esophagus: Is Esophagectomy Associated with Improved Overall Survival?

  2024cites this paper
• Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial

  2024cites this paper
• Conversion surgery for esophageal and esophagogastric junction cancer

  2024cites this paper
• Endobronchial Ultrasonography to Assess and Evaluate Tracheobronchial Tree Invasion in cT4b Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy: Assessment of Resectability

  2024cites this paper
• Role of surgery in T4N0-3M0 esophageal cancer

  2023influential citation
• S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus

  2023cites this paper
• Multimodal Treatment Strategies to Improve the Prognosis of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Narrative Review

  2022cites this paper
• Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysis

  2022cites this paper
• Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil

  2022cites this paper
• Surgical strategies for treatment of clinical T4 esophageal cancer in Japan.

  2021influential citation
• Definitive chemoradiotherapy for clinical T4b esophageal cancer - treatment outcomes, failure patterns, and prognostic factors.

  2021cites this paper
• Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy

  2020cites this paper
• Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients With Clinical T4b Esophageal Cancer

  2020cites this paper
• Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy

  2019cites this paper
• The Benefits of Docetaxel Plus Cisplatin and 5-Fluorouracil Induction Therapy in Conversion to Curative Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma

  2019cites this paper
• S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus

  2019cites this paper
• Surgery is Associated with Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.

  2019cites this paper
• Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma.

  2019cites this paper
• Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review

  2018cites this paper
• Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends

  2018cites this paper
• Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis.

  2018cites this paper
• Surgical robotics for esophageal cancer

  2018cites this paper
• Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the Oesophagus.

  2018cites this paper
• Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion

  2018cites this paper
• Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.

  2018cites this paper
• Klinische Umsetzung und Konsequenzen aus der S3-Leitlinie „Ösophaguskarzinom“

  2018cites this paper
• Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed

  2017cites this paper
• Importance of positron emission tomography for assessing the response of primary and metastatic lesions to induction treatments in T4 esophageal cancer

  2017cites this paper
• Is 18F-FDG-PET useful for predicting R0 resection after induction therapy for initially unresectable locally advanced esophageal carcinoma?

  2017cites this paper
• Stage‐directed individualized therapy in esophageal cancer

  2016cites this paper
• The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer

  2016cites this paper
• Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy

  2015influential citation
• Chemoradiotherapy and surgery for T4 esophageal cancer in Japan

  2015cites this paper
• S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0 – September 2015, AWMF-Registernummer: 021/023OL)

  2015cites this paper
• Induction chemotherapy followed by surgery for advanced oesophageal cancer.

  2015cites this paper
• Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.

  2015cites this paper
• Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.

  2015cites this paper
• Early tumor response to induction chemotherapy or chemoradiotherapy is a significant prognostic predictor in patients with initially unresectable T4 esophageal cancer following subsequent surgery

  2015cites this paper
• Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer

  2015cites this paper
• [Not Available].

  2015cites this paper
• Is the Outcome of a Salvage Surgery for T4 Thoracic Esophageal Squamous Cell Carcinoma Really Poor?

  2014cites this paper
• Bronchoscopic finding determined outcome after chemoradiotherapy in esophageal cancer patients with airway invasion

  2014cites this paper